LT3658132T - Kompozicijos, apimančios aminorūgštis, skirtos panaudoti gydant su mitochondrijų disfunkcija susijusias ligas - Google Patents
Kompozicijos, apimančios aminorūgštis, skirtos panaudoti gydant su mitochondrijų disfunkcija susijusias ligasInfo
- Publication number
- LT3658132T LT3658132T LTEPPCT/IB2018/055425T LT18055425T LT3658132T LT 3658132 T LT3658132 T LT 3658132T LT 18055425 T LT18055425 T LT 18055425T LT 3658132 T LT3658132 T LT 3658132T
- Authority
- LT
- Lithuania
- Prior art keywords
- compositions
- treatment
- amino acids
- related diseases
- mitochondrial dysfunction
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000004065 mitochondrial dysfunction Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000087359A IT201700087359A1 (it) | 2017-07-28 | 2017-07-28 | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| PCT/IB2018/055425 WO2019021135A1 (en) | 2017-07-28 | 2018-07-20 | COMPOSITIONS COMPRISING AMINO ACIDS FOR USE IN THE TREATMENT OF DISEASES RELATED TO MITOCHONDRIAL DYSFUNCTION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3658132T true LT3658132T (lt) | 2022-07-25 |
Family
ID=60628070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/IB2018/055425T LT3658132T (lt) | 2017-07-28 | 2018-07-20 | Kompozicijos, apimančios aminorūgštis, skirtos panaudoti gydant su mitochondrijų disfunkcija susijusias ligas |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11337946B2 (lt) |
| EP (2) | EP3915553A1 (lt) |
| JP (2) | JP7266767B2 (lt) |
| KR (3) | KR102566297B1 (lt) |
| CN (1) | CN110996935A (lt) |
| AU (2) | AU2018306540B2 (lt) |
| BR (1) | BR112020001471A2 (lt) |
| CA (1) | CA3070197A1 (lt) |
| CL (1) | CL2020000220A1 (lt) |
| DK (1) | DK3658132T3 (lt) |
| ES (1) | ES2923126T3 (lt) |
| HU (1) | HUE059050T2 (lt) |
| IT (1) | IT201700087359A1 (lt) |
| LT (1) | LT3658132T (lt) |
| MX (2) | MX2020001083A (lt) |
| MY (1) | MY200975A (lt) |
| PH (1) | PH12020500190A1 (lt) |
| PL (1) | PL3658132T3 (lt) |
| PT (1) | PT3658132T (lt) |
| RS (1) | RS63422B1 (lt) |
| SG (1) | SG11201912103TA (lt) |
| WO (1) | WO2019021135A1 (lt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700087359A1 (it) * | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201700087376A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201900002109A1 (it) * | 2019-02-13 | 2020-08-13 | Professional Dietetics Spa | Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale |
| JP2021038147A (ja) * | 2019-08-30 | 2021-03-11 | 国立大学法人 鹿児島大学 | ミトコンドリア生合成促進剤 |
| IT202000000442A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia |
| IT202000000454A1 (it) * | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro |
| IT202000021664A1 (it) * | 2020-09-14 | 2022-03-14 | Iaf Network S P A | Formulazione amminoacidica bilanciata |
| TW202308604A (zh) * | 2021-05-10 | 2023-03-01 | 國立大學法人東北大學 | 肌肉量增加用組成物 |
| IT202100029726A1 (it) * | 2021-11-24 | 2023-05-24 | Professional Dietetics Spa | Composizioni oftalmiche per il trattamento di lesioni corneali |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE555780T1 (de) * | 1997-10-24 | 2012-05-15 | John P Blass | Nahrungsergänzungsmittel für metabolische hirnleistungsstörungen |
| DE10000577A1 (de) | 2000-01-10 | 2001-07-26 | Fumapharm Ag Muri | Verwendung von Fumarsäurederivaten zur Behandlung mitochondrialer Krankheiten |
| ITTO20010580A1 (it) * | 2001-06-15 | 2002-12-15 | Professional Dietetics Srl | Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete. |
| ITTO20010804A1 (it) | 2001-08-08 | 2003-02-08 | Professional Dietetics Srl | Composizioni a base di aminoacidi, idonee alla terapia per la cicatrizzazione e/o riparazione di ferite e lesioni, in particolare per l'appl |
| US6620850B2 (en) | 2001-09-19 | 2003-09-16 | University Of Florida | Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors |
| US20060063827A1 (en) * | 2004-09-23 | 2006-03-23 | Yu Ruey J | Systemic administration of therapeutic amino acids and N-acetylamino acids |
| ITTO20030789A1 (it) | 2003-10-07 | 2005-04-08 | Professional Dietetics Srl | Composizione a base di amino acidi per il trattamento |
| WO2007049818A1 (ja) | 2005-10-27 | 2007-05-03 | Ajinomoto Co., Inc. | 抗脂肪肝、抗肥満及び抗高脂血症用組成物 |
| US7982066B2 (en) * | 2005-12-09 | 2011-07-19 | Novalife, Inc. | High protein supplement |
| JP2007161642A (ja) | 2005-12-14 | 2007-06-28 | Kyowa Hakko Kogyo Co Ltd | アルコール性肝障害抑制剤 |
| TWI551288B (zh) | 2011-02-17 | 2016-10-01 | Ea Pharma Co Ltd | Antimicrobial activity enhancer for chemotherapeutic agents |
| WO2012147901A1 (ja) | 2011-04-28 | 2012-11-01 | 味の素株式会社 | 抗癌剤副作用改善用組成物 |
| US20130084378A1 (en) | 2011-09-30 | 2013-04-04 | Daesang Corporation | Amino acid seasoning compositions comprising l-glutamic acid and l-lysine |
| US9198454B2 (en) | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
| WO2013188874A1 (en) | 2012-06-15 | 2013-12-19 | Gencia Corporation | Methods of mitigating side effects of radiation exposure and chemotherapy |
| CN102772407B (zh) | 2012-08-01 | 2014-09-17 | 岳茂兴 | 一种促进神经损伤修复的药物组合物及其应用 |
| US9597367B2 (en) * | 2013-04-19 | 2017-03-21 | Bioventures, Llc | Methods for improving muscle and heart function |
| US10226441B2 (en) | 2014-12-09 | 2019-03-12 | Nihon Sizen Hakkoh Co., Ltd. | Aging inhibitor |
| MX357998B (es) * | 2015-03-20 | 2018-07-11 | Antonio Hernandez Miramontes Jorge | Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo. |
| CN107708683A (zh) | 2015-05-11 | 2018-02-16 | 纽卡斯尔创新有限公司 | 氨基酸补充 |
| MY187022A (en) | 2015-05-14 | 2021-08-26 | Professional Dietetics Spa | Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy |
| US20180221457A1 (en) | 2015-07-31 | 2018-08-09 | Val-Chum, Limited Partnership | Glycerol-3-phosphate phosphatase activators |
| BR112018010200B1 (pt) | 2015-11-27 | 2022-05-17 | Doublegood Ab | Dose de um suplemento alimentar, uso da dose do suplemento alimentar, e composição alimentar. |
| CN110678172A (zh) | 2017-04-28 | 2020-01-10 | 胺细拉健康公司 | 用于治疗创伤性脑损伤的氨基酸组合物及其使用方法 |
| IT201700087376A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| IT201700087359A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
| CN118078810A (zh) | 2017-10-02 | 2024-05-28 | 佛罗里达大学研究基金会公司 | 用于抑制肿瘤生长的材料和方法 |
| WO2019172287A1 (ja) * | 2018-03-05 | 2019-09-12 | 味の素株式会社 | 認知機能の改善用組成物および不安様症状の改善用組成物、ならびに脳萎縮の抑制用組成物 |
| IT201800006725A1 (it) | 2018-06-27 | 2019-12-27 | Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche | |
| IT201900002109A1 (it) | 2019-02-13 | 2020-08-13 | Professional Dietetics Spa | Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale |
| US20220394508A1 (en) | 2019-11-11 | 2022-12-08 | Lg Electronics Inc. | Vehicular distributed antenna system operating in wireless communication system and method for operating same |
| IT202000000454A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per la prevenzione e il trattamento del cancro |
| IT202000000442A1 (it) | 2020-01-13 | 2021-07-13 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia |
| WO2022266480A1 (en) | 2021-06-17 | 2022-12-22 | Axcella Health Inc. | Methods of predicting liver fat content and uses thereof |
-
2017
- 2017-07-28 IT IT102017000087359A patent/IT201700087359A1/it unknown
-
2018
- 2018-07-20 PL PL18753465.6T patent/PL3658132T3/pl unknown
- 2018-07-20 PT PT187534656T patent/PT3658132T/pt unknown
- 2018-07-20 KR KR1020207003492A patent/KR102566297B1/ko active IP Right Grant
- 2018-07-20 KR KR1020247014645A patent/KR20240063205A/ko active Application Filing
- 2018-07-20 MY MYPI2020000106A patent/MY200975A/en unknown
- 2018-07-20 CA CA3070197A patent/CA3070197A1/en active Pending
- 2018-07-20 LT LTEPPCT/IB2018/055425T patent/LT3658132T/lt unknown
- 2018-07-20 MX MX2020001083A patent/MX2020001083A/es unknown
- 2018-07-20 EP EP21174744.9A patent/EP3915553A1/en active Pending
- 2018-07-20 KR KR1020237026054A patent/KR20230117642A/ko active Application Filing
- 2018-07-20 US US16/634,330 patent/US11337946B2/en active Active
- 2018-07-20 SG SG11201912103TA patent/SG11201912103TA/en unknown
- 2018-07-20 EP EP18753465.6A patent/EP3658132B1/en active Active
- 2018-07-20 ES ES18753465T patent/ES2923126T3/es active Active
- 2018-07-20 BR BR112020001471-0A patent/BR112020001471A2/pt unknown
- 2018-07-20 WO PCT/IB2018/055425 patent/WO2019021135A1/en active Application Filing
- 2018-07-20 DK DK18753465.6T patent/DK3658132T3/da active
- 2018-07-20 JP JP2019566579A patent/JP7266767B2/ja active Active
- 2018-07-20 HU HUE18753465A patent/HUE059050T2/hu unknown
- 2018-07-20 CN CN201880047542.0A patent/CN110996935A/zh active Pending
- 2018-07-20 RS RS20220627A patent/RS63422B1/sr unknown
- 2018-07-20 AU AU2018306540A patent/AU2018306540B2/en active Active
-
2020
- 2020-01-27 MX MX2022010774A patent/MX2022010774A/es unknown
- 2020-01-27 CL CL2020000220A patent/CL2020000220A1/es unknown
- 2020-01-27 PH PH12020500190A patent/PH12020500190A1/en unknown
-
2022
- 2022-04-20 US US17/724,537 patent/US11957651B2/en active Active
-
2023
- 2023-03-08 JP JP2023035509A patent/JP2023071939A/ja active Pending
- 2023-11-14 AU AU2023266256A patent/AU2023266256A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201912103TA (en) | Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases | |
| IL284371A (en) | Amino acid compounds and methods for treating liver diseases | |
| IL256085B (en) | A substituted derivative of cholanoic acid, a pharmaceutical composition comprising it and the substituted derivative for use in treatment | |
| IL253195B (en) | Pharmaceutical preparations containing synthetic glycans for use in the treatment of diseases of the digestive system and methods and methods for their preparation | |
| IL273959A (en) | Methods and preparations for the treatment of rare diseases | |
| EP3337465A4 (en) | Compositions and methods of use in combination for the treatment and diagnosis of autoimmune diseases | |
| PL3577135T3 (pl) | Kompozycja farmaceutyczna do stosowania do leczenia lub zapobiegania chorobom związanym z c5 | |
| IL272336A (en) | Amino acid compounds for the treatment of nerve damage | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| ZA202007834B (en) | Compositions comprising amino acids for use in the prevention and treatment of liver diseases | |
| EP3185862A4 (en) | PROTECTIVE METALOTHION ANALOG COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF PATHOGENIC DISEASES | |
| PL3294279T3 (pl) | Kompozycje zawierające aminokwasy do zastosowania w leczeniu zapalenia błony śluzowej u pacjentów cierpiących na neoplazję poddawanych radioterapii i/lub chemioterapii | |
| IL280389A (en) | Bile acid receptor modulators conjugated to G.1 protein and methods of using them | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| SG11201912098SA (en) | Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases | |
| PL3515409T3 (pl) | Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych | |
| EP3265108A4 (en) | PEPTIDES AND COMPOSITIONS AS WELL AS USES THEREOF IN THE TREATMENT OF DISEASES | |
| PL3006027T3 (pl) | Kompozycje zawierające aminokwasy do stosowania w leczeniu ogólnoustrojowego stanu zapalnego związanego z udarem u pacjentów z dysfagią | |
| IL265911A (en) | Epilimod preparations and methods of using them in the treatment of Alzheimer's disease | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| GB201410869D0 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| GB201718838D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| GB201817346D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of diseases | |
| GB201712742D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| IL243402A0 (en) | Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases |